Document Detail


Overgrowth syndromes: is dysfunctional PI3-kinase signalling a unifying mechanism?
MedLine Citation:
PMID:  12939652     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Studies in drosophila and animal models have shown that the phosphoinositide-3-kinase (PI3-kinase) axis plays a central role in normal development, defining the number and size of cells in tissues. Dysfunction of this pathway leads to growth anomalies and has been established to play a key role in the pathogenesis of Cowden syndrome and tuberous sclerosis. It is probable that dysfunction of this pathway is the basis of other disorders especially those typified by asymmetric overgrowth.
Authors:
Karen T Barker; Richard S Houlston
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of human genetics : EJHG     Volume:  11     ISSN:  1018-4813     ISO Abbreviation:  Eur. J. Hum. Genet.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-08-26     Completed Date:  2004-06-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9302235     Medline TA:  Eur J Hum Genet     Country:  England    
Other Details:
Languages:  eng     Pagination:  665-70     Citation Subset:  IM    
Affiliation:
Section of Cancer Genetics, Institute of Cancer Research, Surrey SM2 5NG, UK. karenb@icr.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / genetics*,  metabolism
Growth Disorders / enzymology,  genetics*
Hamartoma Syndrome, Multiple / genetics,  metabolism
Humans
Proteus Syndrome / genetics,  metabolism
Signal Transduction / genetics*
Tuberous Sclerosis / genetics,  metabolism
Chemical
Reg. No./Substance:
EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy.
Next Document:  Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage.